SourceBio International 

0
0
+€0.00+0% 00:00 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing. In addition, the company offers controlled environment storage services and diagnostic and genomic services and products. Sourcebio International Plc was founded in 1999 and is headquartered in Nottingham, the United Kingdom.
顯示更多
執行長
Mr. Jay Charles LeCoque
員工
339
國家
英國
ISIN
GB00BKSB1674
WKN
000A2QGNC

上市

0 則留言

分享你的想法

常見問題

SourceBio International 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Boerse Stuttgart 交易所,SourceBio International 的股票以代號 6J8.STU 進行交易。
SourceBio International 有多少名員工?▼
截至 2026年11月2日,公司共有 339 名員工。
SourceBio International 位於哪個產業?▼
SourceBio International從事於Health & Wellness產業。
SourceBio International 何時完成拆股?▼
SourceBio International 最近沒有進行任何拆股。
SourceBio International 的總部在哪裡?▼
SourceBio International 的總部位於 英國 的 Nottingham。